Mark Scott, chief executive of Cello Group plc (LON:CLL) tells Proactive they're confident of meeting full-year market expectations after a solid first half.

The Cello Health unit led the way as it grew organically and via the acquisition of Defined Health for £15mln in February, which cements its focus on the US.